Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: A prospective long-term follow-up study

Surgery

Volumn 123, Issue 5, 1998, Pages 573-578

  Roukos, Dimitrios H ^a,b   Lorenz, Mathias ^a   Encke, Albrecht ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH CANCER; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0031925757     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.1998.88094     Document Type: Article

References (26)

1. Akoh JA, MacIntyre IMC. Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 1992;79:293-9.
2. Marujama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 1995;19:532-6.
3. Katai H, Maruyama K, Sasako M, et al. Mode of recurrence after gastric cancer surgery. Digestive Surgery 1994;11:99-103.
4. Sasako M, McCulloch P, Kinoshita T, Marujama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995;82:346-51.
5. Soreide JA, van-Heerden JA, Burger LJ, Donohue JH, Sarr MG, Ilstrup DM. Surgical aspects of patients with adenocarcinoma operated on for cure. Arch Surg 1996;131:481-6.
6. Wanebo HJ, Kennedy BJ, Winchester DP, Fremgen A, Stewart AK. Gastric carcinoma: does lymph node dissection alter survival? J Am Coll Surg 1996;183:616-24.
7. Siewert JR, Boettcher K, Roder JD, Busch R, Hermanek P, Meyer HJ, et al. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 1993;80:1015-8.
8. Pacellli F, Doglieto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 1993;80:1153-6.
9. Dent DM, Madden MV, Price SK. Randomised comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988;75:110-12.
10. Robertson CS, Chung SCS, Woods SDS, et al. A prospective randomised trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994;220:176-82.
11. Bonenkamp JJ, van de Velde CJH, Hermans J. Randomised trial of extended lymph node dissection for gastric cancer. In: Siewert JR, Roder JD, editors. 2nd International Gastric Cancer Congress Munich, vol 2. Bologna: Monduzzi Editore; 1997. p 1111-6.
12. Cuschieri A, Payers P, Fielding J, et al. Postoperative morbidity and mortality after Dl and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 1996;347:995-9.
13. Bonenkamp JJ, Songun I, Hermans J, Sasako M, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-8.
14. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
15. Roukos DH, Kappas AM, Encke A. Extensive lymph node dissection in gastric cancer: is it of therapeutic value [editorial]? Cancer Treat Rev 1996;22:247-252.
16. Rohde H, Gebbensleben B, Bauer. P, Stuetzer H, Zieschang J. Has there been any improvement in the staging of gastric cancer? findings from the German Gastric cancer TNM Study Group. Cancer 1989;64:2465-81.
17. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 1981;11:127-39.
18. Hermanek P, Sobin LH, editors. UICC: TNM classification of malignant tumours. 4th ed. Berlin: Springer-Verlag; 1987.
19. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-8.
20. Gehan EA. A generalized Wilcoxon for comparing arbitrary single-censored samples. Biometrica 1965:52:203-24.
21. Marujama K, Okabayashi K, Kinoshita T Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-25.
22. Bunt AMG, Hermans J, Smit VTHBM, van de Velde CJH, Fleuren G J, Bruijn JA. Surgical/pathologic-stage migration confounds comparison of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995;13:19-25.
23. Fass J, Hungs M, Reineke TH, Schumpelic V The impact of D2-lymphadenectomy on staging and prognosis of gastric carcinoma. In: Siewert JR, Roder JD, editors. 2nd International Gastric Cancer Congress Munich, vol 2. Bologna: Monduzzi Editore; 1997. p 1141-6.
24. Siewert JR, Kestlmeier R, Busch R, Boettcher K, Roder JD, Mueller J, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996;83:1144-7.
25. Roukos DH. Extended lymphadenectomy in gastric cancer: when, for whom and why. Ann R Coll Surg Engl 1998;80:16-24.
26. Roukos D, Hottenrott C, Lorenz M, Koutsogiorgas-Couchell S. A critical evaluation of effectiveness of extended lymphadenectomy in patients with carcinoma of the stomach. J Cancer Res Clin Oncol 1990;116:307-13.